Search

Author/Creator den Broeder, Alfons A.

1. Choosing Wisely in Daily Practice: An Intervention Study on Antinuclear Antibody Testing by Rheumatologists. Issue 4 (24th March 2016)

Authors:
Lesuis, Nienke; Hulscher, Marlies E. J. L.; Piek, Ester; Demirel, Hatice; van der Laan‐Baalbergen, Nicole; Meek, Inger; van Vollenhoven, Ronald F.; den Broeder, Alfons A.
Journal:
Arthritis care & research
Issue:
Volume 68:Issue 4(2016:Apr.)
Page Start:
562
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Identification of Risk Factors for COVID‐19 Hospitalization in Patients With Anti‐Rheumatic Drugs: Results From a Multicenter Nested Case Control Study. Issue 5 (23rd February 2022)

Authors:
Opdam, Merel A. A.; Benoy, Sophie; Verhoef, Lise M.; Van Bijnen, Sandra; Lamers‐Karnebeek, Femke; Traksel, René A. M.; Vos, Petra; den Broeder, Alfons A.; Broen, Jasper
Journal:
Clinical pharmacology & therapeutics
Issue:
Volume 111:Issue 5(2022)
Page Start:
1061
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Little Evidence for Usefulness of Biomarkers for Predicting Successful Dose Reduction or Discontinuation of a Biologic Agent in Rheumatoid Arthritis: A Systematic Review. Issue 2 (28th January 2017)

Authors:
Tweehuysen, Lieke; van den Ende, Cornelia H.; Beeren, Fenna M. M.; Been, Evelien M. J.; van den Hoogen, Frank H. J.; den Broeder, Alfons A.
Journal:
Arthritis & rheumatology
Issue:
Volume 69:Issue 2(2017)
Page Start:
301
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Little Evidence for Usefulness of Biomarkers for Predicting Successful Dose Reduction or Discontinuation of a Biologic Agent in Rheumatoid Arthritis: A Systematic Review. Issue 2 (February 2017)

Authors:
Tweehuysen, Lieke; van den Ende, Cornelia H.; Beeren, Fenna M. M.; Been, Evelien M. J.; van den Hoogen, Frank H. J.; den Broeder, Alfons A.
Journal:
Arthritis & rheumatology
Issue:
Volume 69:Issue 2(2017)
Page Start:
301
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Pharmacokinetic boosting to enable a once-daily reduced dose of tofacitinib in patients with rheumatoid arthritis and psoriatic arthritis (the PRACTICAL study). (December 2022)

Authors:
van der Togt, Céleste J.T.; Verhoef, Lise M.; van den Bemt, Bart J.F.; den Broeder, Nathan; ter Heine, Rob; den Broeder, Alfons A.
Journal:
Therapeutic advances in musculoskeletal disease
Issue:
Volume 14(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Serum drug levels and anti-drug antibodies in the context of dose tapering by interval prolongation of adalimumab, etanercept and ustekinumab in psoriasis patients: results of the CONDOR trial. (4th July 2022)

Authors:
Atalay, Selma; Berends, Sophie E.; Groenewoud, Hans M. M.; Mathot, Ron A. A.; Njoo, David M.; Mommers, Johannes M.; Ossenkoppele, Paul M.; Koetsier, Marjolein I. A.; Berends, Maartje A.; de Vries, Annick; van de Kerkhof, Peter C. M.; den Broeder, Alfons A.; de Jong, Elke M. G. J.; van den Reek, J...
Journal:
Journal of dermatological treatment
Issue:
Volume 33:Number 5(2022)
Page Start:
2680
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open‐Label Transition From Reference Infliximab to Biosimilar Infliximab. Issue 1 (7th December 2017)

Authors:
Tweehuysen, Lieke; van den Bemt, Bart J. F.; van Ingen, Iris L.; de Jong, Alphons J. L.; van der Laan, Willemijn H.; van den Hoogen, Frank H. J.; den Broeder, Alfons A.
Journal:
Arthritis & rheumatology
Issue:
Volume 70:Issue 1(2018)
Page Start:
60
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗